SIMTRIYO
LIVE

Serial Number

79436678

Owner

Otsuka Pharmaceutical Co., Ltd.

Attorney

Kazuyo Morita

Filing Date

Sep 11, 2025

Add to watchlist:

No watchlists yet
View on USPTO

SIMTRIYO Trademark

Serial Number: 79436678

SIMTRIYO is a trademark filed by Otsuka Pharmaceutical Co., Ltd. on September 11, 2025. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Otsuka Pharmaceutical Co., Ltd. (566 trademarks)

Chiyoda-ku, Tokyo , JP

Entity Type: 03

Trademark Details

Filing Date

September 11, 2025

Registration Date

Not Registered

Published for Opposition

June 2, 2026

Goods & Services

Pharmaceutical preparations for the treatment of central nervous system diseases and disorders; pharmaceutical preparations for the treatment of attention deficit hyperactivity disorder, binge eating disorder and major depressive disorder; pharmaceutical preparations, namely, smoking cessation preparations.

Filing History

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 2, 2026 NPUB
PUBLISHED FOR OPPOSITION
Jun 2, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 27, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 4, 2026 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 30, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 30, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 30, 2026 TROA
ATTORNEY REVIEW COMPLETED
Apr 16, 2026 ATRV
CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED
Apr 13, 2026 CREV
REFUSAL PROCESSED BY IB
Mar 26, 2026 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 12, 2026 RFCS
REFUSAL PROCESSED BY MPU
Mar 12, 2026 RFRR
CORRECTION TRANSACTION RECEIVED FROM IB
Feb 26, 2026 CRCV
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Feb 10, 2026 RFCR
NON-FINAL ACTION WRITTEN
Feb 9, 2026 CNRT
ASSIGNED TO EXAMINER
Feb 2, 2026 DOCK
APPLICATION FILING RECEIPT MAILED
Jan 30, 2026 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 30, 2026 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Dec 1, 2025 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Nov 13, 2025 REPR